ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EU nod for Vertex CF therapy Kaftrio pharmatimes
August 24, 2020Vertex Pharmaceuticals' Kaftrio (ivacaftor/tezacaftor/elexacaftor) has been approved by the European Commission for use in combination with ivacaftor to treat people aged 12 years and older with certain forms of cystic fibrosis.
Pharma Sources Insight January 2025
